JAMA[journal] 检索结果

901. Expanding Pathways to Major Journals for Early-Career Researchers.

作者: Michael O Mensah.;K Jane Muir.;Jasmine Travers Altizer.;Hermioni L Amonoo.;Abigail Arons.;Crystal E Brown.;Lisa M McElroy.;Kendra D Sims.
来源: JAMA. 2025年334卷16期1428-1430页

902. The New Clinician-Scholars-Dual Training in Medicine and Humanities Drives Health Research Innovation.

作者: Vinayak Jain.;Kayla Zamanian.;Lakshmi Krishnan.
来源: JAMA. 2025年334卷16期1419-1420页

903. Is Acrodynia a New Disease?

来源: JAMA. 2025年334卷14期1305页

904. Unseen Scars.

作者: Adam B Weiner.
来源: JAMA. 2025年334卷16期1425页

905. What Is Endometriosis?

作者: Rebecca Voelker.
来源: JAMA. 2025年334卷24期2240页

906. Midurethral Sling vs OnabotulinumtoxinA for Urinary Incontinence-Reply.

作者: Heidi S Harvie.;Christopher Chermansky.;Holly E Richter.
来源: JAMA. 2025年334卷16期1488-1489页

907. To Improve Health in the United States, Focus on Women.

作者: Sarah M Temkin.
来源: JAMA. 2025年334卷14期1225-1226页

908. Timing of Antihypertensive Medications and Cardiovascular Outcomes.

作者: Jianping Zhu.;Weixing Zhang.
来源: JAMA. 2025年334卷16期1485页

909. Timing of Antihypertensive Medications and Cardiovascular Outcomes.

作者: Ming Gao.;Tengfei Cao.;Qian Wu.
来源: JAMA. 2025年334卷16期1486页

910. Timing of Antihypertensive Medications and Cardiovascular Outcomes-Reply.

作者: Scott R Garrison.;Michael R Kolber.;Christina S Korownyk.
来源: JAMA. 2025年334卷16期1486-1487页

911. Timing of Antihypertensive Medications and Cardiovascular Outcomes.

作者: Jonathan Cedernaes.;Christian Benedict.
来源: JAMA. 2025年334卷16期1485-1486页

912. Donor-Derived Epstein-Barr Virus Infection Among Pediatric Kidney Transplant Recipients.

作者: Vishnu S Potluri.;Sandra Amaral.;Chethan M Puttarajappa.;Siqi Zhang.;Kaitlin J Devine.;Peter P Reese.;Elizabeth M Sonnenberg.
来源: JAMA. 2025年334卷16期1482-1484页

913. Timing of Antihypertensive Medications and Cardiovascular Outcomes.

作者: Suyin Feng.;Hua Li.;Runfeng Sun.
来源: JAMA. 2025年334卷16期1484-1485页

914. Everolimus and Low-Dose Tacrolimus After Heart Transplant in Children: A Randomized Clinical Trial.

作者: Christopher S Almond.;Kevin P Daly.;Erin L Albers.;Juan C Alejos.;Rebecca Ameduri.;Scott R Auerbach.;Lynsey Barkoff.;Aliessa P Barnes.;Matthew J Bock.;Arene Butto.;Waldemar F Carlo.;Chesney D Castleberry.;Maryanne R Chrisant.;Shriprasad R Deshpande.;William J Dreyer.;Melanie D Everitt.;Brian Feingold.;Selena Gonzales.;Seth A Hollander.;Steven J Kindel.;Gloria L Klein.;Ashwin K Lal.;Jacqueline M Lamour.;Joanne Lee.;Minmin Lu.;Irene D Lytrivi.;Shelley D Miyamoto.;Elfriede Pahl.;David M Peng.;Thomas D Ryan.;Tajinder P Singh.;Jennifer A Su.;David L Sutcliffe.;A Marian Ybarra.;Steven Zangwill.;Joseph W Rossano.;Lynn A Sleeper.; .
来源: JAMA. 2025年334卷15期1339-1348页

Studies suggest that everolimus may reduce the risk of rejection, cardiac allograft vasculopathy (CAV), chronic kidney disease (CKD), and cytomegalovirus (CMV) after heart transplant. Everolimus use is controversial because of data demonstrating higher infection deaths when everolimus is introduced de novo after transplant. It is unclear whether everolimus is safe and effective when initiated at 6 months posttransplant in children, a population in which median graft survival is limited to 15 years and randomized clinical trials are lacking.

915. A 2-Month-Old Boy With Pink Papules and Plaques.

作者: Po-Chien Wu.;Cheng-Hsun Chiu.;I-Hsin Shih.
来源: JAMA. 2025年334卷16期1476-1477页

916. Audio Highlights: August 22, 2025.

来源: JAMA. 2025年334卷11期e2418934页

917. Tracking County-Level Measles Cases in the US.

作者: Farzin Ahmadi.;Ensheng Dong.;Lauren M Gardner.
来源: JAMA. 2025年334卷23期2130-2132页

918. Error in Figure 4 and References.

来源: JAMA. 2025年334卷13期1203页

919. Developing New Therapies-Putting the Money Where the Need Is.

作者: Ellen J MacKenzie.;Donald M Berwick.;Alex M Helman.
来源: JAMA. 2025年334卷16期1421-1422页

920. Individualized Prediction of Platelet Transfusion Outcomes in Preterm Infants With Severe Thrombocytopenia.

作者: Hilde van der Staaij.;Ilaria Prosepe.;Camila Caram-Deelder.;Ruth H Keogh.;Emöke Deschmann.;Christof Dame.;Wes Onland.;Sandra A Prins.;Florian Cassel.;Esther J d'Haens.;Elke van Westering-Kroon.;Peter Andriessen.;Sabine L Vrancken.;Christian V Hulzebos.;Daniel C Vijlbrief.;Suzanne F Fustolo-Gunnink.;Karin Fijnvandraat.;Enrico Lopriore.;Johanna G van der Bom.;Nan van Geloven.
来源: JAMA. 2025年334卷14期1267-1277页

Preterm infants with severe thrombocytopenia (platelet count <50 × 109/L) frequently receive platelet transfusions. However, it is unclear in what cases prophylactic transfusion truly reduces bleeding risk or whether it does more harm than good.

结果排序

文献格式

出版时间

出版类型

出版语言